Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Dermatology

Building Your Care Team and Preparing for Your Visit

At a Glance

Managing moderate-to-severe atopic eczema requires a multidisciplinary care team. To get the most from your specialist visit, bring a detailed log of past treatments, clear photos of your worst flares, and use symptom tracking tools to communicate the true impact of your condition.

Managing atopic eczema, especially when it is moderate-to-severe, requires more than just a single doctor. Because it is a systemic disease, the most successful outcomes often come from a multidisciplinary team [1]. This team may include:

  • Dermatologist: The lead specialist for managing skin inflammation and prescribing advanced therapies [2].
  • Allergist/Immunologist: To manage related conditions like asthma, food allergies, or hay fever [3].
  • Primary Care Physician or Pediatrician: To oversee overall health and coordinate screenings [1].
  • Mental Health Professional: Chronic itch and sleep loss can lead to significant psychological distress; these specialists help manage the “burden of disease” [4].

Preparing for Your First Appointment

To help your specialist understand the severity of your eczema, you should bring “physical artifacts” of your medical history. This helps move your care forward more quickly by showing what hasn’t worked [5].

  • Treatment Log: A list of every topical steroid or cream you have used, including its potency (strength), how many weeks/months you used it, and if it helped [2].
  • Biopsy and Lab Results: Copies of any past skin biopsies, allergy patch tests, or blood work [2].
  • Symptom Photos: Since eczema flares can come and go, bring clear photos of your skin at its worst to show the doctor what they may not see on the day of the visit.

Objective Communication Tools

Doctors often see a “snapshot” of your skin during an exam, which may not reflect your daily struggle. Use validated Patient-Reported Outcome Measures (PROMs) to bridge this gap [4].

  • RECAP (Recap of Atopic Eczema): A simple tool that measures how well your eczema was controlled over the previous week [6].
  • ADCT (Atopic Dermatitis Control Tool): A questionnaire that captures the subjective parts of your disease—like itch severity, sleep loss, and the impact on your mood—which a physical exam might miss [7][8].
    Using these tools consistently allows you and your doctor to see if a treatment is truly working over months, not just days [9][10].

Vetting Your Specialist

To ensure your care team is current with modern medical standards, look for a specialist who moves beyond traditional steroids. You can evaluate their expertise by asking:

  1. “How many patients do you currently have on targeted biologics or JAK inhibitors?” (Experienced doctors should have a large number of patients on these newer therapies) [11].
  2. “What is your protocol for managing the side effects of advanced therapies?” (They should be able to clearly explain monitoring requirements like blood tests) [12].
  3. “Do you follow the ‘tiered’ treatment ladder from the latest guidelines?” (This ensures they are using an evidence-based approach rather than over-relying on systemic steroids) [5].

Back to Home

Common questions in this guide

Which types of doctors treat moderate-to-severe atopic eczema?
Severe atopic eczema is best managed by a multidisciplinary team. This usually includes a dermatologist to treat skin inflammation, an allergist for related conditions like asthma, and sometimes a mental health professional to help with the emotional impact of chronic itch.
What should I bring to my first dermatologist appointment for eczema?
Bring a detailed log of all past topical steroids or creams you have used, including their strength and how long you used them. It is also highly recommended to bring clear photos of your skin during its worst flares, along with any past biopsy or allergy test results.
How can I accurately communicate my eczema severity to my doctor?
You can use validated patient questionnaires like RECAP or the Atopic Dermatitis Control Tool (ADCT). These simple tools help you objectively track your itch severity, sleep loss, and the impact the disease has on your daily mood between doctor visits.
What questions should I ask to vet a new eczema specialist?
Ask how many patients they currently treat with targeted biologics or JAK inhibitors, which indicates their experience with modern therapies. You should also ask about their treatment plan if your current therapy fails and how they monitor for medication side effects.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with moderate-to-severe eczema are currently in your practice receiving targeted biologics or JAK inhibitors?
  2. 2.If my current treatment fails, what specific 'step-up' therapies will we consider next, and why?
  3. 3.What is your protocol for long-term safety monitoring (like blood tests or shingles screening) if we start a JAK inhibitor?
  4. 4.How do you coordinate care with other specialists, like an allergist or a sleep specialist, to manage my eczema as a systemic disease?
  5. 5.What are your thoughts on using oral prednisone for long-term management compared to newer targeted therapies?
  6. 6.Am I a candidate for proactive maintenance therapy?
  7. 7.What objective signs mean I need to step up to systemic treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Understanding Atopic Dermatitis: Pathophysiology and Management Strategies.

    Chai H, Siu WS, Ma H, Li Y

    Biomolecules 2025; (15(11)) doi:10.3390/biom15111500.

    PMID: 41301418
  2. 2

    The management of severe eczema in pregnancy.

    Keeling E, Smith CH, Woolf RT

    Clinical medicine (London, England) 2025; (25(1)):100282 doi:10.1016/j.clinme.2024.100282.

    PMID: 39733910
  3. 3

    Atopic Dermatitis in Adults.

    Silverberg JI

    The Medical clinics of North America 2020; (104(1)):157-176 doi:10.1016/j.mcna.2019.08.009.

    PMID: 31757234
  4. 4

    Measurement properties of patient-reported outcome measures for eczema control: a systematic review.

    Stuart BL, Howells L, Pattinson RL, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(10)):1987-1993 doi:10.1111/jdv.17335.

    PMID: 33977561
  5. 5

    Atopic eczema.

    Brown SJ

    Clinical medicine (London, England) 2016; (16(1)):66-9 doi:10.7861/clinmedicine.16-1-66.

    PMID: 26833520
  6. 6

    Cross-Cultural Validation of the RECAP of Atopic Eczema Question-naire in a Swedish Population.

    Sigurdardottir G, Alsterholm M, Andersson CD, et al.

    Acta dermato-venereologica 2024; (104()):adv38889 doi:10.2340/actadv.v104.38889.

    PMID: 38898676
  7. 7

    Describing atopic dermatitis in real-world clinical practice: a retrospective health system analysis.

    Polaskey MT, Chovatiya R

    Archives of dermatological research 2025; (317(1)):365 doi:10.1007/s00403-025-03892-x.

    PMID: 39920465
  8. 8

    Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study.

    Lee HJ, Woo Y, Lee YB, et al.

    Acta dermato-venereologica 2025; (105()):adv40704 doi:10.2340/actadv.v105.40704.

    PMID: 39936606
  9. 9

    Evaluation and work-up of atopic dermatitis.

    Zhu J, Abuabara K

    Journal of the American Academy of Dermatology 2026; (94(5S)):S24-S27 doi:10.1016/j.jaad.2026.02.094.

    PMID: 42209109
  10. 10

    Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis.

    Saeki H, Kataoka Y, Etoh T, et al.

    Dermatology and therapy 2024; (14(2)):533-543 doi:10.1007/s13555-023-01094-9.

    PMID: 38326699
  11. 11

    Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.

    Davis DMR, Drucker AM, Alikhan A, et al.

    Journal of the American Academy of Dermatology 2024; (90(2)):e43-e56 doi:10.1016/j.jaad.2023.08.102.

    PMID: 37943240
  12. 12

    Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.

    Nash P, Kerschbaumer A, Dörner T, et al.

    Annals of the rheumatic diseases 2021; (80(1)):71-87 doi:10.1136/annrheumdis-2020-218398.

    PMID: 33158881

This page provides educational information on preparing for eczema doctor visits. It does not replace professional medical advice, diagnosis, or treatment. Always consult your healthcare provider regarding your specific care plan.

Get notified when new evidence is published on atopic eczema.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.